Erwin M. Jongedijk
Impact in
-
- Antibiotic Use and Resistance
-
- Tuberculosis Research and Epidemiology
- Antifungal resistance and susceptibility
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 8
-
- Tuberculosis Research and Epidemiology 4
- HIV/AIDS drug development and treatment 2
- Co-authors
- Jan‐Willem C. Alffenaar (13 shared papers)Daan J. Touw (13 shared papers)Remco A. Koster (4 shared papers)Samiksha Ghimire (4 shared papers)Scott K. Heysell (3 shared papers)Tjip S. van der Werf (3 shared papers)J. Boonstra (2 shared papers)Jos G. W. Kosterink (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Chromatography B (2 papers)Bioanalysis (1 paper)European Respiratory Journal (1 paper)
- Partner nations
- NetherlandsAustraliaUnited States
In The Last Decade
Erwin M. Jongedijk
15 papers receiving 236 citations
Peers
Comparison fields: 5 of 57
- Applied Microbiology and Biotechnology 11
- Infectious Diseases 100
- Pharmacology 85
- Transplantation 9
- Geriatrics and Gerontology 7
Countries citing papers authored by Erwin M. Jongedijk
This map shows the geographic impact of Erwin M. Jongedijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin M. Jongedijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin M. Jongedijk more than expected).
Fields of papers citing papers by Erwin M. Jongedijk
This network shows the impact of papers produced by Erwin M. Jongedijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin M. Jongedijk. The network helps show where Erwin M. Jongedijk may publish in the future.
Co-authors
The 25 scholars most cited alongside Erwin M. Jongedijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 34 | |
| 2 | 2020 | 25 | |
| 3 | 2020 | 24 | |
| 4 | 2019 | 23 | |
| 5 | 2018 | 21 | |
| 6 | 2021 | 19 | |
| 7 | 2018 | 17 | |
| 8 | 2021 | 16 | |
| 9 | 2015 | 16 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 10 | |
| 12 | 2023 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2023 | 5 | |
| 15 | 2020 | 5 |
About Erwin M. Jongedijk
Erwin M. Jongedijk is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Immunology and Surgery, having authored 15 papers that have together received 242 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Tuberculosis Research and Epidemiology (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Pneumonia and Respiratory Infections (3 papers), HIV/AIDS drug development and treatment (2 papers), Analytical Chemistry and Chromatography (2 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (11 citations), Infectious Diseases (100 citations), Pharmacology (85 citations), Transplantation (9 citations) and Geriatrics and Gerontology (7 citations). Erwin M. Jongedijk has collaborated with scholars based in Netherlands, Australia and United States. Frequent co-authors include Jan‐Willem C. Alffenaar, Daan J. Touw, Remco A. Koster, Samiksha Ghimire, Scott K. Heysell, Tjip S. van der Werf, J. Boonstra, Jos G. W. Kosterink, Stellah Mpagama and Judith Bruchfeld. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Journal of Chromatography B, Bioanalysis and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.